Browse
Subject
Showing results 1,719 to 1,758 of 21,350
- B ANALOG (1)
- B cell receptor (1)
- B lymphocyte (1)
- B MYOBLOC (1)
- B-18 (1)
- B-CELL (1)
- B-cell depleting therapy (1)
- B-CELL DEPLETION (1)
- B-cell depletion therapy (1)
- B-CELL LYMPHOMA (6)
- B-CELL LYMPHOMAS (1)
- B-CELL-LYMPHOMA (1)
- B-CELLS (2)
- B-RAF (1)
- B/AKT (1)
- B27 (1)
- B7 costimulatory molecule (1)
- B7 FAMILY (1)
- B7 보조자극분자 (1)
- B7-H1 (5)
- B7-H1 antigen (2)
- B7-H1 EXPRESSION (2)
- B7-H1 PD-L1 (1)
- B7-H3 LIGAND EXPRESSION (1)
- baby box (1)
- BACILLI (1)
- Bacillus anthracis (1)
- Bacillus Calmette-Guerin (1)
- Back extensors (1)
- BACK-PAIN (2)
- Back-propagating action potential (1)
- BACKGROUND INFUSION (1)
- background parenchyma (1)
- Backgrounds: Hepatotoxicity is one of the most common adverse reaction of anti-tuberculosis(TB) treatment. Relatively little is known about hepatotoxicity and their serum levels of anti-TB drugs. Objective: To investigate the incidence of drug-induced hepatotoxicity (DIH) caused by anti-TB drugs and to identify the association of DIH and serum anti-tuberculosis drug concentrations. Methods: Serum levels of isoniazid (INH) (1)
- BACKPROPAGATING ACTION-POTENTIALS (1)
- BACKSCATTER (1)
- BACTEC MGIT 960 (1)
- Bacteraemia (6)
- bacteraemia (4)
- BACTEREMIA (11)